<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05059717</url>
  </required_header>
  <id_info>
    <org_study_id>2016-1115</org_study_id>
    <secondary_id>NCI-2019-02483</secondary_id>
    <secondary_id>2016-1115</secondary_id>
    <nct_id>NCT05059717</nct_id>
  </id_info>
  <brief_title>An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases</brief_title>
  <official_title>Imaging Tissue Motion Using MR Displacement Encoding With Stimulated Echo (DENSE): Detection of Early Chemotherapy Related Liver Injury Prior to Resection of Colorectal Liver Metastases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial studies how well a magnetic resonance imaging technique called Displacement&#xD;
      Encoding with Stimulated Echo (DENSE) works in detecting chemotherapy-related liver injury in&#xD;
      patients with colorectal cancer that has spread to the liver and can be removed by surgery.&#xD;
      Researchers want to learn if the DENSE technique improves the standard MRI method.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. This is an exploratory study to collect Magnetic Resonance Displacement Encoding with&#xD;
      Stimulated Echo (MR DENSE) imaging data of patients treated with chemotherapy prior to&#xD;
      resection of metastases to explore its utility in detecting sinusoidal liver injury.&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. Estimate sensitivity of MR DENSE (determine degree of 2 dimensional [2D] vector&#xD;
      displacement with cardiac cycle and variability of measurements with cardiac ventricle&#xD;
      contraction).&#xD;
&#xD;
      II. Determine detection of sinusoidal injury (sinusoidal fibrosis, necrosis of pericentral&#xD;
      hepatocytes, narrowing and fibrosis of central veins) on biopsy with non-alignment of 2D&#xD;
      point vectors (horizontal and vertical direction) from neighboring/immediate adjacent points&#xD;
      on MR DENSE imaging.&#xD;
&#xD;
      III. Determine correlation of intra-operative surgical scores (liver color and texture) with&#xD;
      non-alignment of 2D point vectors (horizontal and vertical direction) from&#xD;
      neighboring/immediate adjacent points on MR DENSE imaging.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients undergo standard of care magnetic resonance imaging (MRI) and then undergo an MRI of&#xD;
      the liver using MR DENSE imaging sequences over 60-90 minutes. Healthy volunteers undergo MRI&#xD;
      of the liver using DENSE imaging sequences.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 12, 2018</start_date>
  <completion_date type="Anticipated">July 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Magnetic Resonance Displacement Encoding with Stimulated Echo (MR DENSE) imaging data of patients treated with chemotherapy prior to resection of metastases to explore its utility in detecting sinusoidal liver injury.</measure>
    <time_frame>through study completion, an average of a year.</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Colorectal Carcinoma Metastatic in the Liver</condition>
  <arm_group>
    <arm_group_label>Diagnostic (standard of care MRI, MR DENSE MRI)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo standard of care MRI and then undergo an MRI of the liver using MR DENSE imaging sequences over 60-90 minutes. Healthy volunteers undergo MRI of the liver using DENSE imaging sequences.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Magnetic Resonance Imaging</intervention_name>
    <description>Undergo standard of care MRI</description>
    <arm_group_label>Diagnostic (standard of care MRI, MR DENSE MRI)</arm_group_label>
    <other_name>Magnetic Resonance Imaging Scan</other_name>
    <other_name>Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance</other_name>
    <other_name>MR Imaging</other_name>
    <other_name>MRI</other_name>
    <other_name>MRI Scan</other_name>
    <other_name>NMR Imaging</other_name>
    <other_name>NMRI</other_name>
    <other_name>Nuclear Magnetic Resonance Imaging</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Magnetic Resonance Imaging</intervention_name>
    <description>Undergo MR DENSE imaging</description>
    <arm_group_label>Diagnostic (standard of care MRI, MR DENSE MRI)</arm_group_label>
    <other_name>Magnetic Resonance Imaging Scan</other_name>
    <other_name>Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance</other_name>
    <other_name>MR Imaging</other_name>
    <other_name>MRI</other_name>
    <other_name>MRI Scan</other_name>
    <other_name>NMR Imaging</other_name>
    <other_name>NMRI</other_name>
    <other_name>Nuclear Magnetic Resonance Imaging</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients treated with neoadjuvant chemotherapy and scheduled for hepatectomy, per&#xD;
             standard of care at our institution, and meet criteria for hepatectomy.&#xD;
&#xD;
          -  No contraindications to MRI (such implanted ferromagnetic or pump devices, metallic&#xD;
             fragments in eye), as indicated on our departmental MRI screening form.&#xD;
&#xD;
          -  Patient who is able to undergo informed consent.&#xD;
&#xD;
          -  Men and non-pregnant women.&#xD;
&#xD;
          -  Metastatic disease limited to liver.&#xD;
&#xD;
          -  Metastases involving no more than 6 liver segments.&#xD;
&#xD;
          -  No radiographic evidence of involvement of the hepatic artery, major bile ducts, main&#xD;
             portal vein, celiac/para aortic lymph nodes.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to MRI.&#xD;
&#xD;
          -  Inability to comply with study and/or follow-up procedures.&#xD;
&#xD;
          -  Unable to provide informed consent.&#xD;
&#xD;
          -  Presence of extrahepatic metastatic disease.&#xD;
&#xD;
          -  Metastases involving more than 6 liver segments.&#xD;
&#xD;
          -  Radiographic evidence of involvement of the hepatic artery, major bile ducts, main&#xD;
             portal vein, celiac/para aortic lymph nodes.&#xD;
&#xD;
          -  Pregnant women.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Priya Bhosale</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://mdanderson.org</url>
    <description>M D Anderson Cancer Center</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 9, 2021</study_first_submitted>
  <study_first_submitted_qc>September 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

